Eli Lilly Corp. buy SVB Leerink LLC
Start price
18.12.25
/
50%
€907.10
Target price
18.12.26
-
Performance (%)
17.58%
Price
10.08.26
€1,066.6
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC currently has a performance of 17.58%. This prediction currently runs until 18.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 9.496% | 9.496% |
| iShares Core DAX® | 1,00 % | 4,83 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % |
| iShares S&P 500 | 1,77 % | 1,27 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Ratings data for LLY provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€758.50
27.04.26
27.04.26
€902.26
27.04.27
27.04.27
40.62%
10.08.26
10.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€920.00
07.02.26
07.02.26
€1,097.5
07.02.27
07.02.27
15.93%
10.08.26
10.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€807.50
10.11.25
10.11.25
€955.18
10.11.26
10.11.26
32.09%
10.08.26
10.08.26